The Valley Desk

NCT04346615 · Interventional trial

Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen

Overall registry status Terminated

Phase 2 · Phase 3

Conditions COVID-19 Infection

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov